Evidence map›Paper›PMID 31580700›Full record

ArticleAIDS research and human retroviruses2020

Characterization of HIV-1 CRF01_AE

Maho Sasaki, Tomohiro Kotaki, Siti Qamariyah Khairunisa, Shingo Tachibana, Youdiil Ophinni, Yoshitake Hayashi, Nasronudin, Masanori Kameoka

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and human retroviruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Maho SasakiDepartment of Public Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Tomohiro KotakiDepartment of Public Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Siti Qamariyah KhairunisaIndonesia-Japan Collaborative Research Centre for Emerging and Re-Emerging Infectious Diseases, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
Shingo TachibanaDepartment of Public Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Youdiil OphinniDivision of Molecular Medicine & Medical Genetics, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
Yoshitake HayashiDivision of Molecular Medicine & Medical Genetics, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
NasronudinIndonesia-Japan Collaborative Research Centre for Emerging and Re-Emerging Infectious Diseases, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
Masanori KameokaDepartment of Public Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Kobe University · JPAirlangga University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To eradicate human immunodeficiency virus type 1 (HIV-1) infection, a comprehensive strategy including preventive vaccine development is needed. Envelope glycoproteins (Env) play a central role in viral infection and are the major targets of humoral immune responses. Therefore, Env is a candidate vaccine antigen, and its characterization is necessary for vaccine development. The characterization of the transmitted/founder (T/F; i.e., recently infected) virus that is responsible for the establishment of infection and induction of primary anti-HIV-1 immune responses is important. We herein established HIV-1

Indexed as

Antibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusGenotypeHIV-1HIV AntibodiesHIV InfectionsHumansIndonesiaPhylogenySequence Analysis, DNAAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesCRF01_AEHIV-1 envelope glycoproteinsIndonesiarecent infectiontransmitted/founder virus

Identifiers

PMID31580700
PMCPMC7071041
OpenAlexW2972036670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.